{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:56:39Z","timestamp":1781142999431,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["CTSA award No. UL1 TR002243"],"award-info":[{"award-number":["CTSA award No. UL1 TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00240-022-01326-1","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T10:13:43Z","timestamp":1651486423000},"page":"401-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proton pump inhibitors use and risk of incident nephrolithiasis"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-6596","authenticated-orcid":false,"given":"Wilson","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"1326_CR1","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999\u20132012. JAMA 314:1818\u20131831. https:\/\/doi.org\/10.1001\/jama.2015.13766","journal-title":"JAMA"},{"key":"1326_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","volume":"176","author":"AJ Schoenfeld","year":"2016","unstructured":"Schoenfeld AJ, Grady D (2016) Adverse effects associated with proton pump inhibitors. JAMA Intern Med 176:172\u2013174. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7927","journal-title":"JAMA Intern Med"},{"key":"1326_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thome F, Broich K, Maier W, Fink A et al (2016) Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 73:410\u2013416. https:\/\/doi.org\/10.1001\/jamaneurol.2015.4791","journal-title":"JAMA Neurol"},{"key":"1326_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","volume":"67","author":"KS Cheung","year":"2018","unstructured":"Cheung KS, Chan EW, Wong AYS, Chen L, Wong ICK, Leung WK (2018) Long-term proton pump inhibitors and risk of gastric cancer development after treatment for helicobacter pylori: a population-based study. Gut 67:28\u201335. https:\/\/doi.org\/10.1136\/gutjnl-2017-314605","journal-title":"Gut"},{"key":"1326_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1586\/17512433.2013.811206","volume":"6","author":"SM Wilhelm","year":"2013","unstructured":"Wilhelm SM, Rjater RG, Kale-Pradhan PB (2013) Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol 6:443\u2013451. https:\/\/doi.org\/10.1586\/17512433.2013.811206","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1326_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/gutjnl-2018-316416","volume":"68","author":"QY Wan","year":"2019","unstructured":"Wan QY, Wu XT, Li N, Du L, Zhou Y (2019) Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants. Gut 68:762\u2013764. https:\/\/doi.org\/10.1136\/gutjnl-2018-316416","journal-title":"Gut"},{"key":"1326_CR7","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1681\/ASN.2015121377","volume":"27","author":"Y Xie","year":"2016","unstructured":"Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z (2016) Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 27:3153\u20133163. https:\/\/doi.org\/10.1681\/ASN.2015121377","journal-title":"J Am Soc Nephrol"},{"key":"1326_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J et al (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238\u2013246. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7193","journal-title":"JAMA Intern Med"},{"key":"1326_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/j.gastro.2017.05.046","volume":"153","author":"DCF Klatte","year":"2017","unstructured":"Klatte DCF, Gasparini A, Xu H, de Deco P, Trevisan M, Johansson ALV et al (2017) Association between proton pump inhibitor use and risk of progression of chronic kidney disease. Gastroenterology 153:702\u2013710. https:\/\/doi.org\/10.1053\/j.gastro.2017.05.046","journal-title":"Gastroenterology"},{"key":"1326_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.02.053","author":"M Simonov","year":"2020","unstructured":"Simonov M, Abel EE, Skanderson M, Masoud A, Hauser RG, Brandt CA et al (2020) Use of proton pump inhibitors increases risk of incident kidney stones. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.053","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1326_CR11","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41598-019-39335-7","volume":"9","author":"T Makunts","year":"2019","unstructured":"Makunts T, Cohen IV, Awdishu L, Abagyan R (2019) Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. Sci Rep 9:2282. https:\/\/doi.org\/10.1038\/s41598-019-39335-7","journal-title":"Sci Rep"},{"key":"1326_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112558","volume":"9","author":"CH Park","year":"2014","unstructured":"Park CH, Kim EH, Roh YH, Kim HY, Lee SK (2014) The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS ONE 9:e112558. https:\/\/doi.org\/10.1371\/journal.pone.0112558","journal-title":"PLoS ONE"},{"key":"1326_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-5347(17)48819-7","volume":"133","author":"MK Li","year":"1985","unstructured":"Li MK, Blacklock NJ, Garside J (1985) Effects of magnesium on calcium oxalate crystallization. J Urol 133:123\u2013125","journal-title":"J Urol"},{"key":"1326_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/nep.12330","volume":"19","author":"JH William","year":"2014","unstructured":"William JH, Nelson R, Hayman N, Mukamal KJ, Danziger J (2014) Proton-pump inhibitor use is associated with lower urinary magnesium excretion. Nephrology 19:798\u2013801. https:\/\/doi.org\/10.1111\/nep.12330","journal-title":"Nephrology"},{"key":"1326_CR15","first-page":"371","volume":"20","author":"CY Pak","year":"1994","unstructured":"Pak CY (1994) Citrate and renal calculi: an update. Miner Electrolyte Metab 20:371\u2013377","journal-title":"Miner Electrolyte Metab"},{"key":"1326_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02719-0","author":"PM Patel","year":"2020","unstructured":"Patel PM, Kandabarow AM, Aiwerioghene E, Blanco-Martinez E, Hart S, Leehey DJ et al (2020) Proton-pump inhibitors associated with decreased urinary citrate excretion. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-020-02719-0","journal-title":"Int Urol Nephrol"},{"key":"1326_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jbi.2014.02.003","volume":"52","author":"I Danciu","year":"2014","unstructured":"Danciu I, Cowan JD, Basford M, Wang X, Saip A, Osgood S et al (2014) Secondary use of clinical data: the vanderbilt approach. J Biomed Inform 52:28\u201335. https:\/\/doi.org\/10.1016\/j.jbi.2014.02.003","journal-title":"J Biomed Inform"},{"key":"1326_CR18","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ki.1997.443","volume":"52","author":"GA Quamme","year":"1997","unstructured":"Quamme GA (1997) Renal magnesium handling: new insights in understanding old problems. Kidney Int 52:1180\u20131195. https:\/\/doi.org\/10.1038\/ki.1997.443","journal-title":"Kidney Int"},{"key":"1326_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/089277901750161638","volume":"15","author":"BF Schwartz","year":"2001","unstructured":"Schwartz BF, Bruce J, Leslie S, Stoller ML (2001) Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol 15:233\u2013235. https:\/\/doi.org\/10.1089\/089277901750161638","journal-title":"J Endourol"},{"key":"1326_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/jcph.316","volume":"54","author":"N Markovits","year":"2014","unstructured":"Markovits N, Loebstein R, Halkin H, Bialik M, Landes-Westerman J, Lomnicky J et al (2014) The association of proton pump inhibitors and hypomagnesemia in the community setting. J Clin Pharmacol 54:889\u2013895. https:\/\/doi.org\/10.1002\/jcph.316","journal-title":"J Clin Pharmacol"},{"key":"1326_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jcph.672","volume":"56","author":"JH William","year":"2016","unstructured":"William JH, Danziger J (2016) Magnesium deficiency and proton-pump inhibitor use: a clinical review. J Clin Pharmacol 56:660\u2013668. https:\/\/doi.org\/10.1002\/jcph.672","journal-title":"J Clin Pharmacol"},{"key":"1326_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1345\/aph.1R556","volume":"47","author":"CP Luk","year":"2013","unstructured":"Luk CP, Parsons R, Lee YP, Hughes JD (2013) Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Ann Pharmacother 47:773\u2013780. https:\/\/doi.org\/10.1345\/aph.1R556","journal-title":"Ann Pharmacother"},{"key":"1326_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","volume":"36","author":"MW Hess","year":"2012","unstructured":"Hess MW, Hoenderop JG, Bindels RJ, Drenth JP (2012) Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther 36:405\u2013413. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05201.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1326_CR24","first-page":"134","volume":"11","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman JM, Assimos DG (2009) Hypocitraturia: pathophysiology and medical management. Rev Urol 11:134\u2013144","journal-title":"Rev Urol"},{"key":"1326_CR25","doi-asserted-by":"publisher","first-page":"c49","DOI":"10.1159\/000080252","volume":"98","author":"CY Pak","year":"2004","unstructured":"Pak CY (2004) Medical management of urinary stone disease. Nephron Clin Pract 98:c49-53. https:\/\/doi.org\/10.1159\/000080252","journal-title":"Nephron Clin Pract"},{"key":"1326_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1515\/CCLM.2003.008","volume":"41","author":"S Allie","year":"2003","unstructured":"Allie S, Rodgers A (2003) Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation. Clin Chem Lab Med 41:39\u201345. https:\/\/doi.org\/10.1515\/CCLM.2003.008","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl 14","key":"1326_CR27","first-page":"S351","volume":"10","author":"A Rodgers","year":"1999","unstructured":"Rodgers A (1999) Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation. J Am Soc Nephrol 10(Suppl 14):S351\u2013S354","journal-title":"J Am Soc Nephrol"},{"key":"1326_CR28","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/CJN.09750913","volume":"10","author":"J Blaine","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10:1257\u20131272. https:\/\/doi.org\/10.2215\/CJN.09750913","journal-title":"Clin J Am Soc Nephrol"},{"key":"1326_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","volume":"103","author":"JD Mackay","year":"2010","unstructured":"Mackay JD, Bladon PT (2010) Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM 103:387\u2013395. https:\/\/doi.org\/10.1093\/qjmed\/hcq021","journal-title":"QJM"},{"key":"1326_CR30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63:871\u2013880. https:\/\/doi.org\/10.1136\/gutjnl-2012-304269","journal-title":"Gut"},{"key":"1326_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.ajkd.2010.08.031","volume":"57","author":"ME Vlasschaert","year":"2011","unstructured":"Vlasschaert ME, Bejaimal SA, Hackam DG, Quinn R, Cuerden MS, Oliver MJ et al (2011) Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis 57:29\u201343. https:\/\/doi.org\/10.1053\/j.ajkd.2010.08.031","journal-title":"Am J Kidney Dis"},{"key":"1326_CR32","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1053\/j.gastro.2021.08.005","volume":"161","author":"B Xia","year":"2021","unstructured":"Xia B, Yang M, Nguyen LH, He Q, Zhen J, Yu Y et al (2021) Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of 3 prospective cohorts. Gastroenterology 161:1842-1852.e10. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.005","journal-title":"Gastroenterology"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-022-01326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-022-01326-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-022-01326-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T11:05:18Z","timestamp":1658315118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-022-01326-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s00240-022-01326-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742105007.793592910","asserted-by":"object"}]},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}